Diseases
The promise of diagnosing illnesses with small amounts of blood, saliva, or urine has gained significant attention in recent years, particularly with the emergence of companies like Haemanthus. However, the science behind this claim is a far cry from the revolutionary promise of Theranos, a biotech company that was valued
Diseases
The US Food and Drug Administration (FDA) has cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer's disease. The Lumipulse G pTau217/b-Amyloid 1-42 Plasma Ratio, developed by Fujirebio Diagnostics, Inc., measures two proteins found in human plasma and calculates
Diseases
U.S. health officials have endorsed the first blood test that can help diagnose Alzheimer's and identify patients who may benefit from drugs that can modestly slow the memory-destroying disease. The test, developed by Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a
Diseases
The US Food and Drug Administration (FDA) has given marketing clearance to a blood test that can aid in the early detection of Alzheimer's disease, the first of its kind to receive signoff in the United States. Developed by Fujirebio Diagnostics Inc., the test measures two proteins in
Diseases
Researchers at Nanchang University in People's Republic of China have published a new study on osteopontin's (OPN) role in chronic inflammatory diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and atherosclerosis. The study highlights OPN's multifunctional nature, its contribution to inflammation, and its potential
Diseases
Researchers at Apollonia University conducted a study to investigate the effectiveness of two salivary biomarkers, interleukin-1 beta (IL-1b) and matrix metalloproteinase-8 (MMP-8), in early detection and staging of periodontal disease. The study involved 189 patients who provided unstimulated saliva samples, which were analyzed to quantify IL-1b and MMP-8 levels. Clinical
Diseases
Scientists have taken a major step forward in unraveling the mysteries of chronic traumatic encephalopathy (CTE), a devastating and poorly understood brain disease linked to repetitive head injury. Using advanced spatial transcriptomics, researchers have mapped gene expression in CTE lesions and identified a distinctive 21-gene "signature" that highlights
Diseases
New research underscores the importance of immunohistology in the diagnostic evaluation of renal biopsies. According to the study, immunohistology has become integral to diagnosing and classifying various glomerular renal diseases, with specific protein or antigen-based classification having prognostic and therapeutic implications. The analysis of a renal biopsy is made complex
Diseases
A new study published in The New England Journal of Medicine showcases a novel CRISPR gene therapy that has successfully treated a rare genetic disease in a single patient. The therapy, which involves substituting a single nucleotide to correct a specific mutation, demonstrates the potential of gene editing for therapeutic
Diseases
Data presented by researchers at the University of Kentucky provide new insights into the mechanisms of fatty liver disease, a condition that affects nearly one-quarter of the global population. Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by hepatic steatosis, and research has identified neurotensin (NTS) as a key factor
Diseases
Kidney diseases are rapidly becoming one of the most pressing global health concerns, with high mortality rates and limited treatment options. A new study from the National Autonomous University of Mexico (UNAM) sheds light on the critical role of redox signaling in the regulation of mitochondrial and endoplasmic reticulum homeostasis
Diseases
A recent study published in Biomedicines has shed light on the potential of FAPi PET/CT imaging in identifying fibrosis in immune-mediated inflammatory diseases (IMIDs). Researchers from Amsterdam University Medical Centers have conducted a comprehensive review of available evidence on FAPi PET/CT imaging in various IMIDs, including interstitial lung
